A1CF | APOBEC1 complementation factor | | | | | | Tissue enhanced |
AAAS | Achalasia, adrenocortical insufficiency, alacrimia | Disease related genes
| | | | | Expressed in all |
AADAC | Arylacetamide deacetylase | Enzymes
| | | | | Tissue enhanced |
AADACL3 | Arylacetamide deacetylase-like 3 | | | | | | Group enriched |
AADAT | Aminoadipate aminotransferase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
AAED1 | AhpC/TSA antioxidant enzyme domain containing 1 | | | | | | Expressed in all |
AAGAB | Alpha- and gamma-adaptin binding protein | Disease related genes
| | | | | Expressed in all |
AAK1 | AP2 associated kinase 1 | Enzymes
| | | | | Expressed in all |
AAMDC | Adipogenesis associated, Mth938 domain containing | | | | | | Expressed in all |
AAMP | Angio-associated, migratory cell protein | Plasma proteins
| | | | | Expressed in all |
AAR2 | AAR2 splicing factor homolog (S. cerevisiae) | | | | | | Expressed in all |
AARD | Alanine and arginine rich domain containing protein | | | | | | Tissue enriched |
AARS | Alanyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
AARS2 | Alanyl-tRNA synthetase 2, mitochondrial | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
AARSD1 | Alanyl-tRNA synthetase domain containing 1 | | | | | | Expressed in all |
AASDHPPT | Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | | | | | | Expressed in all |
AASS | Aminoadipate-semialdehyde synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Mixed |
AATF | Apoptosis antagonizing transcription factor | | | | | | Expressed in all |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ABCE1 | ATP-binding cassette, sub-family E (OABP), member 1 | Mitochondrial proteins
| | | | | Expressed in all |
ABCF1 | ATP-binding cassette, sub-family F (GCN20), member 1 | Plasma proteins
| | | | | Expressed in all |
ABCF2 | ATP-binding cassette, sub-family F (GCN20), member 2 | | | | | | Expressed in all |
ABCF3 | ATP-binding cassette, sub-family F (GCN20), member 3 | | | | | | Expressed in all |
ABHD11 | Abhydrolase domain containing 11 | Disease related genes
| | | | | Expressed in all |
ABHD12B | Abhydrolase domain containing 12B | | | | | | Tissue enriched |
ABHD14A-ACY1 | ABHD14A-ACY1 readthrough (NMD candidate) | | | | | | Mixed |
ABHD14B | Abhydrolase domain containing 14B | Plasma proteins
| | | | | Expressed in all |
ABHD16B | Abhydrolase domain containing 16B | Plasma proteins
| | | | | Mixed |
ABHD17A | Abhydrolase domain containing 17A | | | | | | Expressed in all |
ABHD17B | Abhydrolase domain containing 17B | | | | | | Expressed in all |
ABHD17C | Abhydrolase domain containing 17C | | | | | | Mixed |
ABHD4 | Abhydrolase domain containing 4 | Enzymes
| | | | | Expressed in all |
ABHD5 | Abhydrolase domain containing 5 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ABHD8 | Abhydrolase domain containing 8 | | | | | | Mixed |
ABI1 | Abl-interactor 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
ABI2 | Abl-interactor 2 | Cytoskeleton related proteins
| | | | | Expressed in all |
ABI3 | ABI family, member 3 | | | | | | Tissue enhanced |
ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| | | | | Expressed in all |
ABLIM1 | Actin binding LIM protein 1 | | | | | | Expressed in all |
ABLIM2 | Actin binding LIM protein family, member 2 | | | | | | Tissue enhanced |
ABLIM3 | Actin binding LIM protein family, member 3 | Plasma proteins
| | | | | Tissue enhanced |
ABR | Active BCR-related | | | | | | Expressed in all |
ABRA | Actin-binding Rho activating protein | | | | | | Group enriched |
ABRACL | ABRA C-terminal like | Plasma proteins
| | | | | Mixed |
ABT1 | Activator of basal transcription 1 | | | | | | Expressed in all |
ABTB1 | Ankyrin repeat and BTB (POZ) domain containing 1 | | | | | | Expressed in all |
ABTB2 | Ankyrin repeat and BTB (POZ) domain containing 2 | | | | | | Mixed |
AC000003.2 | CDNA FLJ25865 fis, clone CBR01927 | | | | | | Not detected |
AC002310.13 | Uncharacterized protein | | | | | | Not detected |